Preveceutical Med Inc New
(PRVCF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5 | 4 | 2 | 2 | 3 |
| Receivables | 4 | 14 | 46 | 47 | 43 |
| TOTAL | $31 | $49 | $61 | $51 | $60 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 1 | 1 | 2 |
| Intangibles | 92 | 96 | 55 | 57 | 60 |
| TOTAL | $93 | $97 | $56 | $58 | $62 |
| Total Assets | $123 | $146 | $117 | $110 | $122 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,562 | 2,532 | 2,525 | 935 | 890 |
| Accounts payable and accrued liabilities | 1,212 | 1,179 | 1,008 | 1,178 | 1,108 |
| TOTAL | $3,774 | $3,711 | $3,533 | $2,112 | $1,998 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 46 | 47 | 47 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,347 | 1,317 |
| TOTAL | $N/A | $N/A | $46 | $1,394 | $1,364 |
| Total Liabilities | $3,774 | $3,711 | $3,579 | $3,506 | $3,362 |
| Shareholders' Equity | |||||
| Common Shares | 14,273 | 14,852 | 14,544 | 14,865 | 14,990 |
| Retained earnings | -20,391 | -20,968 | -20,454 | -22,855 | -22,951 |
| Other shareholders' equity | 2,467 | 2,551 | 2,448 | 4,593 | 4,721 |
| TOTAL | $-3,651 | $-3,565 | $-3,462 | $-3,397 | $-3,241 |
| Total Liabilities And Equity | $123 | $146 | $117 | $110 | $122 |